UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$922M |
| 3 |
Amazon
AMZN
|
+$646M |
| 4 |
Tesla
TSLA
|
+$554M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$496M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.04B |
| 2 |
Linde
LIN
|
+$949M |
| 3 |
ExxonMobil
XOM
|
+$313M |
| 4 |
VMW
VMware, Inc
VMW
|
+$217M |
| 5 |
NVIDIA
NVDA
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Healthcare | 13.37% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
First Financial Corp
THFF
$958M
| $546K | ﹤0.01% |
16,155
-537
| -3% | -$19.3K |
|
2202
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
| $543K | ﹤0.01% |
+12,022
| New | +$526K |
|
2203
DocGo
DCGO
$64.3M
| $541K | ﹤0.01% |
101,523
+20,580
| +25% | +$167K |
|
2204
Fulgent Genetics
FLGT
$470M
| $540K | ﹤0.01% |
20,184
+1,945
| +11% | +$66.4K |
|
|
PFC
2205
DELISTED
Premier Financial Corp. Common Stock
PFC
| $539K | ﹤0.01% |
31,571
-7,417
| -19% | -$139K |
|
|
SLGC
2206
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $538K | ﹤0.01% |
225,201
+25,200
| +13% | +$55.8K |
|
2207
Century Aluminum
CENX
$4.43B
| $537K | ﹤0.01% |
74,728
| – | – |
|
2208
Vita Coco
COCO
$3.82B
| $535K | ﹤0.01% |
+20,535
| New | +$548K |
|
2209
Nano X Imaging
NNOX
$68.2M
| $534K | ﹤0.01% |
81,331
+11,045
| +16% | +$114K |
|
2210
Resources Connection
RGP
$151M
| $533K | ﹤0.01% |
35,748
+2,526
| +8% | +$39.7K |
|
2211
MarineMax
HZO
$759M
| $532K | ﹤0.01% |
16,221
-1,976
| -11% | -$68.7K |
|
2212
Dr. Reddy's Laboratories
RDY
$9.87B
| $531K | ﹤0.01% |
39,735
| – | – |
|
2213
Leonardo DRS
DRS
$12.3B
| $531K | ﹤0.01% |
31,802
+5,902
| +23% | +$99.6K |
|
2214
Theravance Biopharma
TBPH
$874M
| $530K | ﹤0.01% |
61,415
| – | – |
|
2215
Usana Health Sciences
USNA
$408M
| $529K | ﹤0.01% |
9,031
-2,899
| -24% | -$181K |
|
2216
Enbridge
ENB
$119B
| $528K | ﹤0.01% |
15,907
| – | – |
|
|
PRSU
2217
Pursuit Attractions and Hospitality Inc
PRSU
$1.39B
| $528K | ﹤0.01% |
+20,139
| New | +$560K |
|
2218
BioLife Solutions
BLFS
$1.53B
| $527K | ﹤0.01% |
38,184
| – | – |
|
|
TE
2219
T1 Energy
TE
$1.16B
| $525K | ﹤0.01% |
107,279
+10,145
| +10% | +$72.9K |
|
2220
Portillo's
PTLO
$331M
| $524K | ﹤0.01% |
34,050
+9,395
| +38% | +$183K |
|
2221
E.W. Scripps
SSP
$257M
| $524K | ﹤0.01% |
95,534
+29,669
| +45% | +$247K |
|
2222
Luxfer Holdings
LXFR
$456M
| $522K | ﹤0.01% |
39,977
| – | – |
|
|
BRSP
2223
BrightSpire Capital
BRSP
$634M
| $520K | ﹤0.01% |
83,048
-5,688
| -6% | -$38.9K |
|
2224
Genesco
GCO
$425M
| $519K | ﹤0.01% |
16,833
| – | – |
|
2225
Rush Enterprises Class B
RUSHB
$6.04B
| $519K | ﹤0.01% |
11,451
-1
| -0% | -$45 |
|
Similar funds
UBS AM's Q3 2023 Portfolio in Review
As of Q3 2023, UBS AM held 2,762 positions worth $223B, up 8.1% from $206B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM deployed $7.28B of net new capital in Q3 2023, opening 89 new positions and adding to 1,400 existing holdings. Its largest new stake was Kenvue: 8,680,819 shares worth $174M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Abbott, an estimated $1.04B trimmed.
- UBS AM's largest Q3 2023 buy was Kenvue: 8,680,819 shares worth $174M.
- UBS AM added most to Apple in Q3 2023, an estimated $1.01B increase.
- UBS AM's biggest Q3 2023 reduction was Abbott, cutting an estimated $1.04B.
- UBS AM fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $128M.
- UBS AM's ten largest holdings make up 26% of its $223B portfolio in Q3 2023.
- UBS AM opened 89 new positions and closed 174 in Q3 2023.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $223B.
Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.